Suppr超能文献

根据世界卫生组织-国际临床化学联合会第一国际参考物质标准化的147576名瑞典男性和女性的载脂蛋白B和A-I值。

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials.

作者信息

Jungner I, Marcovina S M, Walldius G, Holme I, Kolar W, Steiner E

机构信息

CALAB Research and CALAB Medical Laboratories, S:t Göran Hospital, Stockholm, Sweden.

出版信息

Clin Chem. 1998 Aug;44(8 Pt 1):1641-9.

PMID:9702950
Abstract

Serum concentrations of apolipoprotein (apo) B and apo A-I were measured from 1985-1996 in a Swedish population sample of 83 112 males and 64 464 females, ages <20 to >80 years, using an automated immunoturbidimetric method calibrated against fresh pools of human serum and commercial calibrators. All values were recalculated in 1997 after calibration against the WHO-IFCC First International Reference Materials. The recalculation factor was 1.059 for apo B, whereas for apo A-I, the correction was: y = 0.989x + 0.101. The total CVs for both apo B and A-I were generally <7%. The mean value (+/- SD) for apo B was 1.31 +/- 0.35 g/L in all males and 1.22 +/- 0.36 g/L in all females. The mean apo A-I concentration was 1.36 +/- 0.22 g/L in males-10% lower than in females (1.51 +/- 0.24 g/L). The mean value of apo B increased up to 60 years of age in males and up to 70 years of age in females. apo A-I concentrations changed only slightly with age in both males and females. apo A-I concentrations among Swedes are nearly identical to those reported recently by two American studies and those obtained in a Finnish population sample. Mean apo B concentrations differ somewhat between the populations but mirror-as expected-differences in total cholesterol concentrations. The highest values were noted in Swedish subjects. The Swedish sample population is, to our knowledge, the largest describing the distribution of apo B and A-I in a general population of adult males and females of all ages determined with procedures standardized and traceable to the WHO-IFCC First International Reference Materials.

摘要

1985年至1996年期间,在瑞典一个年龄范围从不到20岁至80岁以上、包含83112名男性和64464名女性的人群样本中,采用针对新鲜人血清池和商业校准品校准的自动免疫比浊法,测定了血清载脂蛋白(apo)B和apo A-I的浓度。1997年,在使用世界卫生组织-国际临床化学联合会(WHO-IFCC)第一国际参考物质校准后,所有数值都重新进行了计算。apo B的重新计算因子为1.059,而apo A-I的校正公式为:y = 0.989x + 0.101。apo B和apo A-I的总变异系数通常均小于7%。所有男性的apo B平均值(±标准差)为1.31±0.35 g/L,所有女性为1.22±0.36 g/L。男性的apo A-I平均浓度为1.36±0.22 g/L,比女性低10%(女性为1.51±0.24 g/L)。男性的apo B平均值在60岁之前上升,女性在70岁之前上升。男性和女性的apo A-I浓度随年龄变化均较小。瑞典人的apo A-I浓度与最近两项美国研究报告的浓度以及在芬兰人群样本中获得的浓度几乎相同。不同人群之间的apo B平均浓度有所差异,但正如预期的那样,反映了总胆固醇浓度的差异。瑞典受试者的数值最高。据我们所知,瑞典样本人群是描述所有年龄段成年男性和女性总体中apo B和apo A-I分布的最大样本,其测定程序是标准化的且可溯源至WHO-IFCC第一国际参考物质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验